• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. DISTAL ATTACHMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. DISTAL ATTACHMENT Back to Search Results
Model Number MH-463
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 08/27/2021
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled, "efficacy of single-balloon overtube for endoscopic submucosal dissection in the proximal colon: a propensity score-matched analysis".Objectives: a single-balloon overtube (sbo) can improve poor scope operability during colonic endoscopic submucosal dissection (esd).We aimed to evaluate the clinical usefulness of sbo for esd in the proximal colon and the predictive factors for cases in which sbo is useful.Methods: a total of 88 tumors located in the proximal colon resected by balloon-assisted esd (ba-esd) using sbo and 461 tumors resected by conventional esd (c-esd) between june 2015 and november 2020 were considered.Seventy-eight tumors each in the ba-esd and c-esd groups were matched by propensity score matching.Esd outcomes were compared between the groups, and a decision tree analysis was performed to explore the predictive factors for cases in which sbo is useful.Results: there were no significant differences between the groups in the major outcomes such as en bloc resection rate (95% vs.99%, p = 0.17), r0 resection rate (92% vs.96%, p = 0.30), mean dissection speed (16 mm2/min vs.16 mm2/min,p = 0.53), and intraoperative perforation rate (5% vs.6%,p = 0.73).Even when considering cases with poor preoperative scope operability, there were no significant differences between the groups.Comparison of tumors =40 mm in diameter between the groups confirmed that the intraoperative perforation rate was significantly lower in the ba-esd group than in the c-esd group (0% vs.24%, p = 0.0188).Conclusion: sbo is useful for esd of tumors =40 mm in diameter in the proximal colon to prevent intraoperative perforation, which usually has a long procedure time.Type of adverse events/number of patients.Intraoperative perforation (ba-esd) (4 patients).Intraoperative perforation (c-esd) (5 patients).Delayed perforation (ba-esd) (1 patients).Postoperative bleeding (ba-esd) (3 patients).Postoperative bleeding (c-esd) (1 patients).Preoperative scope operability (poor) (27+249 = 266).Scope operability (poor) (3+130 = 133).This literature article requires 9 reports.The related patient identifiers are below.The following reports are for the adverse events: (1) c23173087 colonoscope (pcf-q260azi).(2) c23173090 colonoscope (pcf-h290ti).(3) c23173091 standard tip hood (mh-463 as distal attachment).(4) c23173092 dualknife (kd-655l as single use electrosurgical knife kd-650).(5) c23173093 dualknife j (kd-655q as single use electrosurgical knife kd-655).(6) c23173094 tknife nano (kd-612q as single use electrosurgical knife kd-612).(7) c23173096 sbo (st-cb1).In addition, the following reports are for the "scope operability (fair)" scope malfunction.(8) c23173098 pcf-q260azi (iuc gib bending manipulation and insertion tube defects).(9) c23173100 pcf-h290ti (iuc gib bending manipulation and insertion tube defects).This medwatch report is for patient identifier (b)(6).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DISTAL ATTACHMENT
Type of Device
DISTAL ATTACHMENT
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16855902
MDR Text Key314410854
Report Number9614641-2023-00590
Device Sequence Number1
Product Code FDS
UDI-Device Identifier04953170047756
UDI-Public04953170047756
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K984358
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMH-463
Device Lot NumberUNKNOWN(LITERATURE)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/02/2023
Initial Date FDA Received05/02/2023
Supplement Dates Manufacturer Received05/15/2023
Supplement Dates FDA Received05/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-